SCHEMBL4757744

SCHEMBL4757744

CCOC(=O)c1cc(Br)cc(OC)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
PKM P14618 1/20 0.55
CA12 O43570 3/20 0.53
CA1 P00915 3/20 0.53
CA2 P00918 3/20 0.53
CA7 P43166 3/20 0.53
CA9 Q16790 3/20 0.53
CA14 Q9ULX7 3/20 0.53
CYP3A4 P08684 3/20 0.51
HPGD P15428 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.49
ALDH1A1 P00352 2/20 0.48
HSD17B2 P37059 1/20 0.47
MAPT P10636 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C19 P33261 1/20 0.45
ELANE P08246 1/20 0.44
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31135164 1.00 MEN1 (0.55) MEN1KMT2APKMCA12CA1
SCHEMBL14613473 0.89 CA12 (0.60) MEN1KMT2APKMCA12CA1
SCHEMBL3258075 0.89 MEN1 (0.64) MEN1KMT2APKMCA12CA1
SCHEMBL288382 0.86 BRD4 (0.53) MEN1KMT2APKMCA12CA1
SCHEMBL10180584 0.85 CA12 (0.64) CA12CA1CA2CA7CA9
SCHEMBL2712707 0.85 CA12 (0.64) MEN1KMT2ACA12CA1CA2
SCHEMBL1188442 0.84 NOTUM (0.57) MEN1KMT2APKMCA12CA1
SCHEMBL3216583 0.83 MEN1 (0.58) MEN1KMT2APKMCA12CA1
SCHEMBL4328949 0.83 CYP2C19 (0.58) MEN1KMT2APKMCA12CA1
SCHEMBL14374036 0.83 CA12 (0.73) MEN1KMT2APKMCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014186704-A2 NOVEL COMPOUNDS FOR THE TREATMENT OF CYSTIC FIBROSIS N30 PHARMACEUTICALS, INC. (US) 2014-11-20 WO disclosed
WO-2009000819-A1 5-PHENYL-1,3,4-OXADIAZOL-2-YL-ACETYL-4-PIPERIDINYL DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2008-12-31 WO disclosed
WO-2009000819-A1 5-PHENYL-1,3,4-OXADIAZOL-2-YL-ACETYL-4-PIPERIDINYL DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2008-12-31 WO disclosed